Methanobrevibacter species are archaea—microorganisms distinct from bacteria—that mainly reside in the human gut. These microbes are recognized for producing methane gas as a byproduct of fermentation, particularly from hydrogen and carbon dioxide. Elevated levels of Methanobrevibacter spp. have been linked to slowed intestinal transit and symptoms such as constipation and bloating. Unlike many bacteria, archaea are not affected by standard antibiotics, making their overgrowth more challenging to manage. Their presence offers insight into the balance of microbial communities and gas production within the gut.
They are methane-producing archaea commonly found in the human gut, distinct from bacteria.
They affect gas production and intestinal transit; high levels are often associated with constipation and bloating.
No, since they are archaea, they are not affected by typical antibiotics used for bacterial overgrowth.
It may indicate methane-dominant dysbiosis, which is commonly linked to slowed gut motility and functional bowel disorders.